Abstract:Background: A substantial proportion of triple-negative breast cancer (TNBC) patients harbors a germline BRCA1/2 mutation. However, the impact of these mutations on recurrence-free survival (RFS) and overall survival (OS) rates remains controversial.Methods: Medical records of women diagnosed with BC between January 2013 and 2020 in two centers located in Monterrey, Mexico were reviewed. Only stage I-III TNBC patients who had available genetic test results and at least 12 months of followup were considered eli… Show more
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.